Detalhe da pesquisa
1.
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Br J Cancer
; 130(3): 442-449, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102227
2.
Retrospective Evaluation of the Prognostic Value of Histological Growth Pattern in Patients with Colorectal Peritoneal Metastases Undergoing Curative-Intent Cytoreductive Surgery.
Ann Surg Oncol
; 31(6): 3778-3784, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491312
3.
The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.
Ann Surg Oncol
; 30(6): 3320-3328, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754942
4.
Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
Ann Surg Oncol
; 30(3): 1863-1869, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350459
5.
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.
Curr Opin Oncol
; 34(4): 382-388, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35730499
6.
Circulating DNA in the neoadjuvant setting of early stage colon cancer.
Acta Oncol
; 61(10): 1223-1229, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866544
7.
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
Br J Cancer
; 125(7): 911-919, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426663
8.
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials.
Curr Opin Oncol
; 33(4): 372-377, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882526
9.
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.
Int J Cancer
; 146(1): 94-102, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199501
10.
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.
Acta Oncol
; 59(12): 1438-1446, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820683
11.
Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review.
J Surg Oncol
; 119(4): 489-496, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636052
12.
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?
Curr Opin Oncol
; 35(4): 315-317, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285030
13.
ASO Visual Abstract: Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
Ann Surg Oncol
; 30(3): 1872-1873, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402896
14.
ASO Visual Abstract: The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases-A Pilot Study.
Ann Surg Oncol
; 30(6): 3331-3332, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36867176
15.
Systemic Therapies for Advanced Squamous Cell Anal Cancer.
Curr Oncol Rep
; 20(7): 53, 2018 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29728940
16.
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
Int J Cancer
; 140(2): 431-439, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27681944
17.
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
Br J Cancer
; 117(10): 1478-1485, 2017 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934761
18.
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
Oncologist
; 22(4): 402-408, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209745
19.
Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
Oncologist
; 22(6): 728-736, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476941
20.
Editorial: 'All you need is immunotherapy': a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?
Curr Opin Oncol
; 34(4): 379-381, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837708